Health Concerns with Erythritol
Based on the most recent high-quality evidence, erythritol consumption poses significant cardiovascular risks and should be limited, with the European Food Safety Authority establishing an acceptable daily intake (ADI) of 0.5 g/kg body weight per day due to laxative effects, though emerging cardiovascular data suggests even lower intakes may be prudent 1.
Cardiovascular Risks
The most concerning recent findings involve cardiovascular outcomes:
Erythritol enhances platelet reactivity and thrombosis formation at physiological levels, with ingestion causing sustained elevations (>2 days) in plasma levels that reach thresholds associated with heightened clot formation 2
Elevated serum erythritol is associated with increased mortality risk: overall mortality (HR 1.50), cardiovascular disease mortality (HR 1.86), and heart disease mortality (HR 3.03) in prospective cohort studies 3
Higher circulating erythritol levels predict major adverse cardiovascular events (MACE) in multiple validation cohorts, with the highest quartile showing 1.80-2.21 times increased risk compared to the lowest quartile 2
Both erythritol and its metabolite erythronate are associated with heart failure hospitalization, cardiovascular death, and total mortality in older adults, with erythronate additionally linked to coronary heart disease (HR 1.30), stroke (HR 1.40), and various heart failure subtypes 4
Important caveat: These cardiovascular associations are strongest in older adults (≥55 years) and those with elevated diastolic blood pressure (≥88 mmHg) 3.
Gastrointestinal Effects
The primary established adverse effect is dose-dependent laxation:
The EFSA identified 0.5 g/kg body weight as the no observed adverse effect level (NOAEL) for diarrhea, which they set as the ADI 1
Doses of 20-35 g are generally well-tolerated in healthy adults without significant GI symptoms 5
At 50 g single doses, erythritol causes significantly increased nausea and borborygmi (stomach rumbling), but produces far fewer watery stools compared to xylitol at equivalent doses 5
The concern with diarrhea relates to potential electrolyte and water imbalance, particularly with chronic exposure 1
Exposure Assessment and Risk
Current dietary exposure estimates exceed the ADI in high consumers:
- Children: mean exposure 742 mg/kg/day, with 95th percentile at 1532 mg/kg/day for adolescents
- Acute exposure reaches 3531 mg/kg per meal at the 99th percentile in children
- These estimates likely overestimate actual exposure but indicate that individuals with high intake patterns are at risk 1
Long-Term Safety Profile
Chronic toxicity studies provide some reassurance for non-cardiovascular endpoints:
104-week rat studies at doses up to 5.4 g/kg/day showed no carcinogenic effects and no treatment-related morphological changes except benign nephrocalcinosis (common in polyol-fed rats) 6
However, these older animal studies did not assess the cardiovascular and thrombotic effects now identified in human studies
Clinical Implications
For patients, particularly those with cardiovascular risk factors or established disease:
- Limit erythritol intake to well below 0.5 g/kg/day (approximately 35 g for a 70 kg adult)
- Exercise particular caution in older adults (≥55 years), those with hypertension, diabetes, or existing cardiovascular disease
- Be aware that erythritol is both consumed as an artificial sweetener AND produced endogenously, with elevated endogenous production potentially serving as a biomarker of cardiometabolic dysfunction 4, 7
Common pitfall: Assuming all sugar alcohols have equivalent safety profiles—erythritol appears to have distinct cardiovascular effects not necessarily shared by other polyols 7.
The evidence base has evolved dramatically, with 2023-2025 studies revealing cardiovascular concerns that were not apparent in earlier safety assessments focused primarily on GI tolerance and carcinogenicity.